Dr. Michael Danso of Virginia Oncology Associates discusses cutting edge breast cancer treatments. He gave information about PARP inhibitors, and Claudin. Information regarding triple negative breast cancer, BRCA I and BRCA II breast cancer was also discussed.
Link to this comment:
All Comments (0)